Riboflavin Treatment for Essential Tremor Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for essential tremor, such as medications and surgical procedures, are ineffective in completely stopping tremors and often come with significant side effects or risks, failing to prevent or delay the progression of the disease.
Innovation Solution
High doses of riboflavin, either alone or combined with other B vitamins and coenzyme Q10, are administered to alleviate and potentially delay the progression of essential tremor, offering a safer and more effective treatment option.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If beta blockers are used to treat essential tremor, then tremor symptoms are reduced, but significant side effects occur including changes in blood pressure and heart rate
Solution Approach 1:
The patent changes the chemical/physiological parameter by using a different mechanism (GABA modulation) instead of beta-adrenergic blockade, achieving tremor control without cardiovascular side effects
Solution Approach 2:
The patent introduces an intermediary substance (GABA or GABA precursors) that acts through a different physiological pathway to achieve the same therapeutic effect without the harmful intermediate steps of beta-blockade
2Reliability
If Primidone is used to treat essential tremor, then tremor symptoms are reduced, but significant side effects occur including nausea, vomiting, fatigue, and incoordination
Solution Approach 1:
The patent changes the mechanism of action from sodium channel modulation (Primidone) to GABA system modulation, achieving similar tremor control with a different side effect profile that avoids gastrointestinal and coordination issues
3Reliability
If Botulinum Toxin is used to treat tremors, then tremor symptoms are reduced, but weakness of the trembling site occurs interfering with hand and neck function
Solution Approach 1:
The patent changes the mechanism from neuromuscular junction blockade (Botulinum Toxin) to central GABA modulation, achieving tremor control while preserving peripheral muscle strength and function
Solution Approach 2:
The patent uses GABA as an intermediary that acts centrally in the brain to modulate tremor pathways without directly affecting peripheral muscle contraction, thereby preserving strength
4Reliability
If surgical procedures are used to treat severe essential tremor, then tremor symptoms are reduced, but high risks of stroke, infection and death occur
Solution Approach 1:
The patent uses a non-invasive, temporary pharmacological approach (GABA supplementation) instead of permanent surgical intervention, achieving tremor control without the irreversible risks of surgery
Solution Approach 2:
The patent uses GABA as a chemical intermediary that can be administered orally or intravenously to modulate tremor pathways, avoiding the need for physical brain intervention and its associated surgical risks
5Reliability
If existing medications are used to treat essential tremor, then partial tremor improvement is achieved, but disease progression is not prevented or delayed
Solution Approach 1:
The patent changes the approach from symptomatic management to potential disease-modifying therapy by addressing the underlying GABA deficiency, which may slow or prevent disease progression while controlling symptoms
Data Source
AI summary
Essential tremor can effectively be treated with high doses of Riboflavin (vitamin B2), either on its own or coupled with one or more other B vitamins and/or coenzyme Q10 (CoQ10). The treatment constitutes a significant improvement over prior treatment methods in that it not only alleviates essential tremor, but results in better performance of the affected body portion and may delay the progression of the disease. The preferred addition of other B vitamins and/or CoQ10 also provides balance to the nutrient energy requirements of a patient's body.